<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00512226</url>
  </required_header>
  <id_info>
    <org_study_id>0037-07-EMC</org_study_id>
    <nct_id>NCT00512226</nct_id>
  </id_info>
  <brief_title>Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell Thalassemia</brief_title>
  <official_title>Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell Thalassemia Using T2* Cardiac MRI.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HaEmek Medical Center, Israel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wolfson Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>HaEmek Medical Center, Israel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Iron overload is well study in Thalassemia patients and it's not only related to blood
      transfusions, since intestinal iron absorption is also increased in those patients. Sickle
      cell patients didn't develope significant clinical symptoms and signs of iron overload in
      spite frequent transfusions. The purpouse of this study is to assess the iron overload in
      Sickle cell anemia and Sickle cell Thalassemia patients using clinical parameters and cardiac
      T2*MRI in order to determine the cardiac and liver iron.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of Iron overload.</measure>
    <time_frame>December 2008</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Institute the criteria for iron chelator treatment</measure>
    <time_frame>December 2008</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Sickle Cell Anemia</condition>
  <condition>Sickle Cell Thalassemia</condition>
  <condition>Iron Overload</condition>
  <condition>MRI</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cardiac and Liver T2* MRI</intervention_name>
    <description>Laboratory examinations that are routinely used in follow up of those patients and T2* MRI analysis.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All the patients with Sickle cell anemia and Sickle cell Thalasemia that are currently
             in follow up at the Pediatric Hematology Unit

        Exclusion Criteria:

          -  Age below 18 years.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ariel Koren, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pediatric Hematology Unit, Ha'Emek Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pediatric Hematology Unit and Pediatric Dpt B - HaEmek Medical Center</name>
      <address>
        <city>Afula</city>
        <zip>18101</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 5, 2007</study_first_submitted>
  <study_first_submitted_qc>August 6, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 7, 2007</study_first_posted>
  <last_update_submitted>August 25, 2011</last_update_submitted>
  <last_update_submitted_qc>August 25, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 26, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>HaEmek Medical Center, Israel</investigator_affiliation>
    <investigator_full_name>Dr Koren Ariel</investigator_full_name>
    <investigator_title>Head of Pediatric Hematology Unit and Pediatric Dpt B</investigator_title>
  </responsible_party>
  <keyword>Sickle Cell Anemia</keyword>
  <keyword>Sickle Cell Thalassemia</keyword>
  <keyword>Iron Overload</keyword>
  <keyword>MRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
    <mesh_term>Thalassemia</mesh_term>
    <mesh_term>Iron Overload</mesh_term>
    <mesh_term>Anemia, Sickle Cell</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

